However, according to Foulkes et al, there was no association between increasing tumor size and lymph node positivity in BRCA1 mutation-positive breast cancers; tumor size and nodal status were weak predictors of outcomes in BRCA1 mutation carriers (26). This evidence concerns the gene BRCA1 and breast cancer.